Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Maria do Carme Pampín Casal | M | - |
Origo Biopharma SL
 Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | 7 years |
| Julio Castro-Palomino Laria | M | 55 |
Origo Biopharma SL
Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | 7 years |
| Ramon Bosser | M | - |
Origo Biopharma SL
Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | - |
| Andrea Sáez | M | - |
Origo Biopharma SL
Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | - |
| Clara Campas-Moya | M | - |
Origo Biopharma SL
Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| Spain | 5 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Yolanda Falcón
- Personal Network
